e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
Novel strategies for the diagnosis of tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Analysis of C-reactive protein and fibrinogen as possible predictors of secondary fibrosis in pulmonary tuberculosis
B. Prnjavorac, A. Cauševic, S. Semiz, T. Dujic, T. Bego, N. Ireijz, R. Sejdinovic (Tešanj, Sarajevo, Bosnia And Herzegovina)
Source:
Annual Congress 2011 - Novel strategies for the diagnosis of tuberculosis
Session:
Novel strategies for the diagnosis of tuberculosis
Session type:
Thematic Poster Session
Number:
4381
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Prnjavorac, A. Cauševic, S. Semiz, T. Dujic, T. Bego, N. Ireijz, R. Sejdinovic (Tešanj, Sarajevo, Bosnia And Herzegovina). Analysis of C-reactive protein and fibrinogen as possible predictors of secondary fibrosis in pulmonary tuberculosis. Eur Respir J 2011; 38: Suppl. 55, 4381
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
C-reactive protein in pulmonary TB
Source: Annual Congress 2009 - Diagnostic advances in tuberculosis
Year: 2009
The relation of serum interleukin-6 and C-reactive protein to clinical parameters in pulmonary tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 35s
Year: 2004
Circulating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD?
Source: Eur Respir J 2008; 32: 1451-1457
Year: 2008
D-dimer to C-reactive protein (CRP) ratio in patients with suspected pulmonary embolism
Source: Annual Congress 2010 - Pulmonary embolism
Year: 2010
The relationship between level of C-reactive protein in blood serum and clinical manifestations of the disease in patients with pulmonary tuberculosis
Source: Annual Congress 2010 - Tuberculosis: metabolic insights
Year: 2010
C-reactive protein in pulmonary tuberculosis-correlation with extent and severity of the disease
Source: Annual Congress 2012 - Tuberculosis: clinical findings II
Year: 2012
C-reactive protein and platelet-activating factor-acetylhydrolase activity: new predictors of outcome in pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases
Year: 2008
The comparison of diagnostic relevance of protein C, C-reactive protein and endothelin-1 for prediction of lung vessel thrombosis in patients with community-acquired pneumonia
Source: International Congress 2019 – Complex respiratory infections in clinical practice
Year: 2019
Differences in cellular expression of C-reactive protein and serum amyloid A in lung tissue in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Inflammatory mechanisms in COPD
Year: 2012
C-reactive protein levels and clinically important predictive outcomes in stable COPD patients
Source: Eur Respir J 2006; 27: 902-907
Year: 2006
Comparison of two clinical probability scores combined with C-reactive protein and D-dimer in the diagnosis of pulmonary embolism
Source: Annual Congress 2009 - Pulmonary embolism
Year: 2009
Genetic determinants of C-reactive protein in COPD
Source: Eur Respir J 2006; 28: 1156-1162
Year: 2006
C-reactive protein: a new predictor of adverse outcome in pulmonary arterial hypertension
Source: Annual Congress 2009 - Pulmonary circulation
Year: 2009
C-reactive protein and D-dimer with clinical probability score in the exclusion of pulmonary embolism
Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease
Year: 2008
C-reactive protein and serum amyloid A overexpression in lung tissues of chronic obstructive pulmonary disease patients
Source: Annual Congress 2012 - Inflammatory mechanisms in COPD
Year: 2012
Usefulness of inflammatory markers: procalcitonin, neopterin, C-reactive protein and MR-proANP in the follow-up of patients with chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD
Year: 2008
Factors affecting C-reactive protein levels in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2007 - Different aspects of COPD exacerbations
Year: 2007
C-reactive protein (CRP) as a marker of disease severity in community acquired pneumonia patients with sepsis
Source: Annual Congress 2012 - Infections and sepsis in the ICU
Year: 2012
Usefulness of serum procalcitonin levels in pulmonary tuberculosis
Source: Eur Respir J 2011; 37: 371
Year: 2011
Serum leptin, insulin and C-reactive protein (CRP) in patients with pulmonary tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 343s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept